BSE · VENMAX

Venmax Drugs And Pharmaceuticals Ltd

Sector: Healthcare · ISIN: INE154G01022

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,218

of 5,034 stocks

▼ 141W

Peak #4,177 · 02 Oct 2026

Operating in Healthcare, Venmax Drugs And Pharmaceuticals Ltd carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and has a subdued return on equity. Ownership as of Jun 2026.

Market Cap

16.73 Cr

P/E Ratio

68.76

P/B Ratio

1.18

ROE

1.76%

ROCE

1.96%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	2.48 Cr	3.94 Cr	1.55 Cr	1.32 Cr
Net Profit	11.66 L	10.72 L	3.21 L	2.44 L
EPS	0.10	0.21	0.05	0.05
Operating Profit	11.65 L	10.44 L	4.29 L	4.58 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

10.46%

Public

89.54%

PUBLIC BREAKDOWN

Individuals

76.60%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
29 Jan 2009	Other	Consolidation of Shares
29 Jan 2009	Other	Reduction of Capital

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs